Tokyo Tape
Sign in
← Yamashita Health Care Holdings

Quarterly report · Q2

9265.TEDINET S100PWJZ
Period2022-06-01 → 2022-11-30
Filed2023-01-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥27.7bn2022-06-01 → 2022-11-30Cons.Net sales
Revenue¥55.1bn2021-06-01 → 2022-05-31Cons.Net sales (5-year summary)
Revenue¥27.3bn2021-06-01 → 2021-11-30Cons.Net sales
Operating income¥598m2022-06-01 → 2022-11-30Cons.Operating income
Operating income¥663m2021-06-01 → 2021-11-30Cons.Operating income
Ordinary income¥624m2022-06-01 → 2022-11-30Cons.Ordinary income
Ordinary income¥1.0bn2021-06-01 → 2022-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥701m2021-06-01 → 2021-11-30Cons.Ordinary income
Profit before tax¥20m2022-06-01 → 2022-11-30Cons.Income before income taxes
Profit before tax¥713m2021-06-01 → 2021-11-30Cons.Income before income taxes
Net income (owners)−¥201m2022-06-01 → 2022-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥696m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥471m2021-06-01 → 2021-11-30Cons.Profit loss attributable to owners of parent
Net income−¥204m2022-06-01 → 2022-11-30Cons.Profit loss
Net income¥471m2021-06-01 → 2021-11-30Cons.Profit loss
Total assets¥22.9bnat 2022-11-30Cons.Assets
Total assets¥24.1bnat 2022-05-31Cons.Assets
Total assets¥25.1bnat 2021-11-30Cons.Total assets (5-year summary)
Total liabilities¥15.3bnat 2022-11-30Cons.Liabilities
Total liabilities¥16.1bnat 2022-05-31Cons.Liabilities
Net assets / equity¥7.6bnat 2022-11-30Cons.Net assets
Net assets / equity¥8.0bnat 2022-05-31Cons.Net assets
Net assets / equity¥7.9bnat 2021-11-30Cons.Net assets (5-year summary)
Cash and deposits¥1.8bnat 2022-11-30Cons.Cash and deposits
Cash and deposits¥4.0bnat 2022-05-31Cons.Cash and deposits
Cash & equivalents¥1.8bnat 2022-11-30Cons.Cash and cash equivalents
Cash & equivalents¥4.0bnat 2022-05-31Cons.Cash and cash equivalents
Cash & equivalents¥2.4bnat 2021-11-30Cons.Cash and cash equivalents
Cash & equivalents¥3.7bnat 2021-05-31dCons.Cash and cash equivalents
Operating cash flow−¥1.9bn2022-06-01 → 2022-11-30Cons.Net cash provided by used in operating activities
Operating cash flow¥581m2021-06-01 → 2022-05-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥751m2021-06-01 → 2021-11-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥88m2022-06-01 → 2022-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥27m2021-06-01 → 2022-05-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥318m2021-06-01 → 2021-11-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥209m2022-06-01 → 2022-11-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥229m2021-06-01 → 2022-05-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥229m2021-06-01 → 2021-11-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-78.982022-06-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-143.682022-09-01 → 2022-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥272.672021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥184.812021-06-01 → 2021-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥128.292021-09-01 → 2021-11-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio33.2%at 2022-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio33.1%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio31.3%at 2021-11-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-06-01 → 2022-11-30−¥11m
Reconciling Itemsreconcilingrevenue intersegment2022-06-01 → 2022-11-30−¥11m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2022-11-30−¥447m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue2022-06-01 → 2022-11-30¥140m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue external2022-06-01 → 2022-11-30¥140m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue intersegment2022-06-01 → 2022-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentsegment profit2022-06-01 → 2022-11-30¥3m
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue2022-06-01 → 2022-11-30¥27.5bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue external2022-06-01 → 2022-11-30¥27.5bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue intersegment2022-06-01 → 2022-11-30¥11m
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentsegment profit2022-06-01 → 2022-11-30¥1.0bn
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue2022-06-01 → 2022-11-30¥33m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue external2022-06-01 → 2022-11-30¥33m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentsegment profit2022-06-01 → 2022-11-30¥0
—segment totalrevenue2022-06-01 → 2022-11-30¥27.7bn
—segment totalrevenue external2022-06-01 → 2022-11-30¥27.7bn
—segment totalrevenue intersegment2022-06-01 → 2022-11-30¥11m
—segment totalsegment profit2022-06-01 → 2022-11-30¥1.0bn
Reconciling Itemsreconcilingrevenue2021-06-01 → 2021-11-30¥0
Reconciling Itemsreconcilingrevenue intersegment2021-06-01 → 2021-11-30¥0
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2021-11-30−¥415m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue2021-06-01 → 2021-11-30¥136m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue external2021-06-01 → 2021-11-30¥136m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue intersegment2021-06-01 → 2021-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentsegment profit2021-06-01 → 2021-11-30¥3m
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue2021-06-01 → 2021-11-30¥27.2bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue external2021-06-01 → 2021-11-30¥27.2bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue intersegment2021-06-01 → 2021-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentsegment profit2021-06-01 → 2021-11-30¥1.1bn
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue2021-06-01 → 2021-11-30¥34m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue external2021-06-01 → 2021-11-30¥34m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentsegment profit2021-06-01 → 2021-11-30¥0
—segment totalrevenue2021-06-01 → 2021-11-30¥27.3bn
—segment totalrevenue external2021-06-01 → 2021-11-30¥27.3bn
—segment totalrevenue intersegment2021-06-01 → 2021-11-30¥0
—segment totalsegment profit2021-06-01 → 2021-11-30¥1.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 487
ItemContextValueUnit
Other noiPrior1YTDDuration6000000JPY
Other noiCurrentYTDDuration8000000JPY
Non operating incomePrior1YTDDuration41000000JPY
Non operating incomeCurrentYTDDuration34000000JPY
Interest expenses noePrior1YTDDuration1000000JPY
Interest expenses noeCurrentYTDDuration1000000JPY
Foreign exchange losses noePrior1YTDDuration－JPY
Foreign exchange losses noeCurrentYTDDuration2000000JPY
Loss on sales of notes payable noePrior1YTDDuration2000000JPY
Loss on sales of notes payable noeCurrentYTDDuration4000000JPY
Other noePrior1YTDDuration0JPY
Other noeCurrentYTDDuration0JPY
Non operating expensesPrior1YTDDuration4000000JPY
Non operating expensesCurrentYTDDuration7000000JPY
Ordinary incomePrior1YTDDuration701000000JPY
Ordinary incomeCurrentYTDDuration624000000JPY
Receipts from contingent consideration eiPrior1YTDDuration8000000JPY
Receipts from contingent consideration eiCurrentYTDDuration6000000JPY
Gain on step acquisitions eiPrior1YTDDuration4000000JPY
Gain on step acquisitions eiCurrentYTDDuration－JPY
Extraordinary incomePrior1YTDDuration12000000JPY
Extraordinary incomeCurrentYTDDuration6000000JPY
Provision of allowance for doubtful accounts elPrior1YTDDuration－JPY
Provision of allowance for doubtful accounts elCurrentYTDDuration611000000JPY
Extraordinary lossPrior1YTDDuration－JPY
Extraordinary lossCurrentYTDDuration611000000JPY
Income before income taxesPrior1YTDDuration713000000JPY
Income before income taxesCurrentYTDDuration20000000JPY
Income taxes currentPrior1YTDDuration50000000JPY
Income taxes currentCurrentYTDDuration53000000JPY
Income taxes deferredPrior1YTDDuration190000000JPY
Income taxes deferredCurrentYTDDuration170000000JPY
Income taxesPrior1YTDDuration241000000JPY
Income taxesCurrentYTDDuration224000000JPY
Profit lossPrior1YTDDuration471000000JPY
Profit lossCurrentYTDDuration-204000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration－JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-2000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration471000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration-201000000JPY
Profit lossPrior1YTDDuration471000000JPY
Profit lossCurrentYTDDuration-204000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration26000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration2000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration1000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration10000000JPY
Other comprehensive incomePrior1YTDDuration28000000JPY
Other comprehensive incomeCurrentYTDDuration13000000JPY
Comprehensive incomePrior1YTDDuration499000000JPY
Comprehensive incomeCurrentYTDDuration-191000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-05-31pass
balance sheet identityconsolidated 2022-11-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2022-11-30pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2021-11-30pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2022-11-30pass
statement vs summary · operating cash flowconsolidated 2021-06-01/2021-11-30pass
statement vs summary · operating cash flowconsolidated 2022-06-01/2022-11-30pass
statement vs summary · revenueconsolidated 2021-06-01/2021-11-30pass
statement vs summary · revenueconsolidated 2022-06-01/2022-11-30pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2022-11-30pass